Celebrating 20 Years of Training in Botox®, Aesthetic Medicine
and Medical Weight Management

Start Training Now
IAPAM Logo
Aesthetic Medicine Symposium - September 18-21 in Scottsdale, AZ! Secure Your Spot

Celebrating 20 Years of Excellence in Botox®, Aesthetic Medicine & Medical Weight Management Training & Certification

IAPAM Logo
Aesthetic Medicine Symposium — Sept 18–21, Scottsdale, AZ   Secure Your Spot →
Home » Medical Weight Management Library  » Retatrutide Dosage: a Guide

Retatrutide Dosage: a Guide

Last updated: May 15, 2026

Retatrutide is a new medication (still in development and not FDA-approved for treatment at this stage) that holds promise for helping people manage obesity and other related health issues. The latest updates in clinical research, including the TRIUMPH-1 trial, are gathering more data on how different dosage levels impact weight loss and other health outcomes in both overweight and obese individuals.

Retatrutide Dosage
Retatrutide is an investigational therapy currently in clinical development and is not FDA-approved for routine clinical use. Information on this page is provided for educational purposes for licensed healthcare professionals and should not be used as medical advice or as a basis for self-treatment. Retatrutide products marketed online, including those labeled for “research use” or referred to informally as “reta,” are not verified for safety, quality, or sterility and may pose serious risks. Retatrutide should be obtained only through authorized clinical research settings.

What is Retatrutide?

Retatrutide is a multi-functional peptide drug that acts as an agonist of the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This multifaceted approach enhances satiety, increases energy expenditure, and improves glucose metabolism. The drug is designed as a treatment for obesity, type 2 diabetes, and potentially other related metabolic disorders.

While still in the experimental stages, early clinical trials have shown that Retatrutide may be highly effective in reducing body weight and improving blood sugar levels, heralding it as a potential game-changer.

Retatrutide Dosage Chart: A Quick Breakdown

As of now, there isn’t a standardized Retatrutide dosage chart available for public use, primarily because Retatrutide is still in the research and clinical trial phases. The dosages being studied vary, as researchers are trying to determine the most effective and safe amounts for weight management. In the trials, different dosage levels are being tested to see how they impact weight loss and other health markers.

Reserve Your Spot
An IAPAM Clinical Program · 2026
A complete GLP-1 weight-loss program — ready to customize
Live In-Person or Self-Study Online | Diet & Lifestyle Included | Save up to $1,500
An IAPAM Clinical Program · 2026
A complete GLP-1 weight-loss program — ready to customize
Live In-Person or Self-Study Online | Diet & Lifestyle Included | Save up to $1,500
Reserve Your Spot

Retatrutide Dosage for Weight Loss Research

Researchers did a study that lasted nearly a year with 338 adults who were not diabetic but were overweight or obese. These participants were split into six groups and each group received a different amount of the medicine:

1. 1 mg every week for the whole study
2. 2 mg every week for 4 weeks, then 4 mg every week for the rest of the time
3. 4 mg every week for the whole study
4. Starting with 2 mg per week, moving to 4 mg, and then 8 mg weekly for most of the study
5. 4 mg per week for 4 weeks, then 8 mg weekly for the rest of the study
6. Starting with 2 mg per week, increasing to 4 mg, then 8 mg, with the final dose at 12 mg per week

The study showed that the more medicine participants took, the more weight they lost. For example, those on the lowest dose lost about 8.7% of their weight, while those on the highest dose lost 24.2%.

Every participant taking the highest doses of the medication lost at least 5% of their starting weight. They also had improvements in waist size, blood pressure, blood sugar levels, and other health markers, although there wasn’t an increase in “good” cholesterol.

There is also a bigger ongoing study with over 2,000 people to confirm these results and gather more information, which will continue for about 89 weeks.

* Learn about our stand-alone Weight Loss certification or together with our Botox Training program taught by board-certified dermatologists.

Conclusion

It’s too early to be certain, but indications are that Retatrutide represents a potentially pivotal advance in the management of obesity and related disorders. With its unique multi-receptor targeting mechanism, it has the potential to offer significant clinical benefits. However, like all emerging therapies, the pathway to routine clinical use requires a thorough examination of its safety, optimal dosing, and long-term effects.

Again, ongoing studies are working to determine the optimal dosage that provides the best results with minimal side effects. Once these trials are completed and analyzed, they will help determine standardized dosing guidelines for potential future use. Until then, Retatrutide remains in the experimental stage, and its dosage is still under investigation.

As medical weight management continues to grow, many providers strengthen their practices by pairing GLP-1 services with high-demand aesthetic injectables. Expand your clinical skill set with IAPAM’s comprehensive Botox® training program, designed to help healthcare providers confidently add neuromodulator treatments to their aesthetic offerings.

Medical Weight Management Training

Ready to Build a GLP-1 Weight Management Program?

Build the clinical, operational, and business foundations to evaluate GLP-1 weight-management services for your practice—without handing your patient relationships to a corporate intermediary.

Explore GLP-1 Certification Training →
✓Build direct patient relationshipsLearn a practice-centered approach to GLP-1 weight management and patient education.
✓Create a stronger program foundationExplore patient flow, clinical considerations, and practical service-development decisions.
✓Stay informed as the field evolvesBuild context for evidence, protocol, and regulatory considerations that affect medical weight management.
✓Bring business and clinical learning togetherLearn practice-building fundamentals alongside the clinical foundations for responsible growth.

Want to add Botox® training to your broader practice plan? Explore IAPAM’s Botox training options →

Safety Advisory: Retatrutide remains an investigational agent under study and is not approved by the FDA or other major regulatory authorities for general clinical use. Products sold online as retatrutide or “research-only” retatrutide are not regulated or verified, and their contents, labeling, and sterility cannot be assured. Use outside authorized clinical trials is not supported, and patients should be directed to consult a licensed clinician for individualized care.

Disclaimer: The information provided here is for general knowledge only and should not be considered medical advice. For any questions or concerns about your health or medications, please consult your physician or healthcare provider. They are best equipped to provide guidance specific to your medical needs.

Ready to Transform Your Practice with GLP-1s?

Request your Quick Start Checklist for Starting or Integrating a New GLP-1 for Weight Loss Guide.

Request your free copy